Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors
Jacob C. A. Edvinsson, Aida Maddahi, Isabella Mai Christiansen, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Unmet Needs in the Acute Treatment of Migraine
Enrico Bentivegna, Silvia Galastri, Dilara Onan, et al.
Advances in Therapy (2023) Vol. 41, Iss. 1, pp. 1-13
Open Access | Times Cited: 14
New Oral Drugs for Migraine
Nazia Karsan, Peter J. Goadsby
CNS Drugs (2022) Vol. 36, Iss. 9, pp. 933-949
Open Access | Times Cited: 19
MERTK in the rat trigeminal system: a potential novel target for cluster headache?
Jacob C. A. Edvinsson, Caroline Ran, Felicia Jennysdotter Olofsgård, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Identifying Factors Associated with the Efficacy of Lasmiditan 50 mg as an Acute Treatment for Migraine Attacks Under Various Dosing Conditions in Real-World Clinical Practice
Takafumi Tanei, Shun Yamamoto, Satoshi Maesawa, et al.
Neurology International (2025) Vol. 17, Iss. 5, pp. 62-62
Open Access
The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside
Dimos D. Mitsikostas, Christian Waeber, Margarita Sánchez del Río, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 8, pp. 489-505
Closed Access | Times Cited: 10
Wuzhuyu Decoction Relieves Chronic Migraine by Regulating 5-HT1A and 3A Receptors-Mediated CREB Signaling Pathway in Brain and Intestine
Zhimin Song, Meijing Li, Ziwei Zhou, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 426-426
Open Access
Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain
Adriana Della Pietra, Juha R. Savinainen, Rashid Giniatullin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4407-4407
Open Access | Times Cited: 13
Management of cluster headache: Treatments and their mechanisms
Kuan‐Po Peng, Mark J. Burish
Cephalalgia (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 7
The history and rationale of the development of new drugs for migraine treatment
Pedro André Kowacs, Pedro Augusto Sampaio Rocha‐Filho, Mário Fernando Prieto Peres, et al.
Arquivos de Neuro-Psiquiatria (2023) Vol. 81, Iss. 12, pp. 1084-1097
Open Access | Times Cited: 6
Dual action of the cannabinoid receptor 1 ligand arachidonyl-2′-chloroethylamide on calcitonin gene-related peptide release
Isabella Mai Christiansen, Jacob C. A. Edvinsson, Philip Victor Reducha, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Rodent behavior following a dural inflammation model with anti-CGRP migraine medication treatment
Philip Victor Reducha, Jesper Peter Bömers, Lars Edvinsson, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5
Calcitonin Gene-Related Peptide-Mediated Trigeminal Ganglionitis: The Biomolecular Link between Temporomandibular Disorders and Chronic Headaches
Linda Sangalli, Bradley Eli, Sachi Mehrotra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12200-12200
Open Access | Times Cited: 5
Serotonergic Modulation of Neurovascular Transmission: A Focus on Prejunctional 5-HT Receptors/Mechanisms
Abimael González‐Hernández, Bruno A. Marichal‐Cancino, Antoinette MaassenVanDenBrink, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1864-1864
Open Access | Times Cited: 4
Serotonergic Modulation of Neurovascular Transmission: A Focus on Prejunctional 5-Ht Receptors/Mechanisms
Abimael González‐Hernández, Bruno A. Marichal‐Cancino, Antoinette MaassenVanDenBrink, et al.
(2023)
Open Access | Times Cited: 2
Neurophysiological and Vascular Mechanisms of Action of Serotoninergic Drugs for Abortive Migraine Treatment
Alexey Y. Sokolov, I. B. Skiba, O. A. Lyubashina
Neuroscience and Behavioral Physiology (2024) Vol. 54, Iss. 5, pp. 707-725
Closed Access
New Migraine Drugs for Older Adults
Dilara Onan, William David Wells-Gatnik, Enrico Bentivegna, et al.
Drugs & Aging (2023) Vol. 40, Iss. 4, pp. 301-305
Closed Access | Times Cited: 1
MERTK in the trigeminal system: a novel target for cluster headache and other headache disorders?
Jacob C. A. Edvinsson, Lars Edvinsson, Caroline Ran, et al.
Research Square (Research Square) (2024)
Open Access
Self-medication: A Mechanistic Review of Common Drugs
Shiksha Kaushal, Vivek Sharma
International Journal of Pharmaceutical Sciences Review and Research (2023) Vol. 80, Iss. 02
Open Access
Neurophysiological and Vascular Mechanisms of Action of the Serotoninergic Drugs for Abortive Migraine Treatment
Alexey Y. Sokolov, I. B. Skiba, O. A. Lyubashina
Успехи физиологических наук (2023) Vol. 54, Iss. 3, pp. 53-76
Closed Access
Page 1

Scroll to top